{
  "docId": "019de073-9e32-71bd-acba-301a2d9cbf00",
  "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c",
  "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 28,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "cover",
  "function": "front_matter",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/20",
  "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00",
  "deckJsonHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00.json",
  "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-20",
  "components": [
    {
      "bbox": {
        "h": 1,
        "w": 1,
        "x": 0,
        "y": 0
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "47caac7b-252a-460f-aa40-83172f329d90",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.08,
        "y": 0.75
      },
      "kind": "title",
      "text": "Pegtarviliase (formerly AGLE-177) – Potential Best-in-Class Treatment for Homocystinuria",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49389f88-4965-4bb6-bba1-fcae7b958290",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 24,
      "from": 20,
      "beatId": "5fa22bc5-87f2-4946-9705-fa014d063ae3",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 20-24 introduce Pegtarviliase as a potential best-in-class treatment and provide an overview of its innovative approach",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 24,
      "from": 20,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "8d7561ed-879a-4cee-9208-d194f7670c57",
      "evidence": "The deck presents Pegtarviliase as a potential best-in-class treatment",
      "position": 1,
      "objective": "Introduce Pegtarviliase as a solution to address the needs of Classical HCU patients",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.6,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}